Structure‑based identification of SARS‑CoV‑2 main protease inhibitors from anti‑viral specific chemical libraries : an exhaustive computational screening approach

dc.contributor.authorBhowmick, Shovonlal
dc.contributor.authorSaha, Achintya
dc.contributor.authorOsman, Sameh Mohamed
dc.contributor.authorAlasmary, Fatmah Ali
dc.contributor.authorAlmutairi, Tahani Mazyad
dc.contributor.authorIslam, Md Ataul
dc.date.accessioned2022-09-20T04:38:14Z
dc.date.available2022-09-20T04:38:14Z
dc.date.issued2021-08
dc.description.abstractWorldwide coronavirus disease 2019 (COVID-19) outbreak is still threatening global health since its outbreak first reported in the late 2019. The causative novel virus has been designated as severe acute respiratory syndrome coronavirus 2 (SARSCoV- 2). Although COVID-19 emergent with significant mortality, there is no availability of definite treatment measures. It is now extremely desirable to identify potential chemical entities against SARS-CoV-2 for the treatment of COVID-19. In the present study, a state-of-art virtual screening protocol was implemented on three anti-viral specific chemical libraries against SARS-CoV-2 main protease ( Mpro). Particularly, viewing the large-scale biological role of Mpro in the viral replication process it has been considered as a prospective anti-viral drug target. Herein, on collected 79,892 compounds, hierarchical multistep docking followed by relative binding free energy estimation has been performed. Thereafter, implying a user-defined XP-dock and MM-GBSA cut-off scores as −8.00 and −45.00 kcal/mol, chemical space has been further reduced. Exhaustive molecular binding interactions analyses and various pharmacokinetics profiles assessment suggested four compounds (ChemDiv_D658-0159, ChemDiv_F431-0433, Enamine_Z3019991843 and Asinex_LAS_51389260) as potent inhibitors/modulators of SARS-CoV-2 Mpro. In-depth protein–ligand interactions stability in the dynamic state has been evaluated by 100 ns molecular dynamics (MD) simulation studies along with MM-GBSA-based binding free energy estimations of entire simulation trajectories that have revealed strong binding affinity of all identified compounds towards Mpro. Hence, all four identified compounds might be considered as promising candidates for future drug development specifically targeting the SARS-CoV-2 Mpro; however, they also need experimental assessment for a better understanding of molecular interaction mechanisms.en_US
dc.description.departmentChemical Pathologyen_US
dc.description.librarianam2022en_US
dc.description.sponsorshipThe Deanship of Scientific Research at King Saud University.en_US
dc.description.urihttp://link.springer.com/journal/11030en_US
dc.identifier.citationBhowmick, S., Saha, A., Osman, S.M. et al. Structure-based identification of SARS-CoV-2 main protease inhibitors from anti-viral specific chemical libraries: an exhaustive computational screening approach. Molecular Diversity 25, 1979–1997 (2021). https://doi.org/10.1007/s11030-021-10214-6.en_US
dc.identifier.issn1381-1991 (print)
dc.identifier.issn1573-501X (online)
dc.identifier.other10.1007/s11030-021-10214-6
dc.identifier.urihttps://repository.up.ac.za/handle/2263/87224
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.rights© Crown 2021. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License.en_US
dc.subjectMain proteaseen_US
dc.subjectMolecular dockingen_US
dc.subjectVirtual screeningen_US
dc.subjectMolecular dynamicsen_US
dc.subjectMM-GBSAen_US
dc.subjectSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)en_US
dc.subjectCOVID-19 pandemicen_US
dc.subjectCoronavirus disease 2019 (COVID-19)en_US
dc.subject.otherHealth sciences articles SDG-03
dc.subject.otherSDG-03: Good health and well-being
dc.titleStructure‑based identification of SARS‑CoV‑2 main protease inhibitors from anti‑viral specific chemical libraries : an exhaustive computational screening approachen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Bhowmick_Structure_2021.pdf
Size:
4.08 MB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.75 KB
Format:
Item-specific license agreed upon to submission
Description: